SCHEMBL4882006

SCHEMBL4882006

Oc1ccc(-c2n[nH]cc2Oc2cccc(F)c2)c(O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.44
KMT2A Q03164 7/20 0.44
MEN1 O00255 6/20 0.44
LMNA P02545 5/20 0.44
TSHR P16473 4/20 0.44
HTT P42858 3/20 0.44
GAA P10253 3/20 0.44
ALOX15 P16050 2/20 0.44
HSD17B10 Q99714 2/20 0.44
ALDH1A1 P00352 1/20 0.44
GLA P06280 1/20 0.44
ALOX12 P18054 4/20 0.43
GPR55 Q9Y2T6 2/20 0.43
HIF1A Q16665 1/20 0.43
ESR1 P03372 2/20 0.42
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
HTR1A P08908 3/20 0.38
SLC6A2 P23975 3/20 0.38
SLC6A4 P31645 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4884312 0.88 MAPT (0.40) MAPTKMT2AMEN1LMNATSHR
SCHEMBL4873458 0.85 MAPT (0.45) MAPTKMT2AMEN1LMNATSHR
SCHEMBL4890060 0.85 MAPT (0.58) MAPTKMT2AMEN1LMNATSHR
SCHEMBL4881095 0.85 MAPT (0.44) MAPTKMT2AMEN1LMNATSHR
SCHEMBL4884200 0.85 MAPT (0.49) MAPTKMT2AMEN1LMNATSHR
SCHEMBL4881151 0.85 MAPT (0.44) MAPTKMT2AMEN1LMNATSHR
SCHEMBL4883579 0.83 MAPT (0.41) MAPTKMT2AMEN1LMNATSHR
SCHEMBL4884397 0.82 AMY1A (0.48) MAPTKMT2AMEN1LMNATSHR
SCHEMBL4881056 0.82 MAPT (0.42) MAPTKMT2AMEN1LMNATSHR
SCHEMBL4874645 0.81 MAPT (0.44) MAPTKMT2AMEN1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799649-B1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS MERCK PATENT GMBH (DE) 2014-06-25 EP claimed
US-20080090880-A1 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2008-04-17 US claimed
EP-1799649-A1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS Merck Patent GmbH (DE) 2007-06-27 EP claimed
WO-2006039977-A1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS MERCK PATENT GMBH (DE) 2006-04-20 WO claimed
EP-1799649-B1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS MERCK PATENT GMBH (DE) 2014-06-25 EP disclosed
US-20080090880-A1 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2008-04-17 US disclosed
EP-1799649-A1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS Merck Patent GmbH (DE) 2007-06-27 EP disclosed
WO-2006039977-A1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS MERCK PATENT GMBH (DE) 2006-04-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090880-A1 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators HSP90AB1, HSP90AA1, HSP90AB2P MAPT 2220/4885KMT2A 4029/4885MEN1 4568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.